Adyen to Provide Payment Technology Services for LillyDirect
Direct-to-consumer options may enable new convenience for
"The
LillyDirect will leverage Adyen's platform to continue offering patients flexible payment options, including credit and debit cards, digital wallets such as Apple Pay and Google Pay, and HSA/FSA cards. Adyen's fraud prevention, reconciliation, and analytics capabilities will reduce friction throughout the checkout process while supporting a secure end-to-end experience.
The platform's scalability provides LillyDirect with a foundation to continuously enhance payment options as patient needs evolve. Transactions will utilize Adyen's Intelligent Payment Routing, an AI-powered feature that automatically selects the most efficient
To learn more about Adyen, visit adyen.com.
About Adyen
Adyen (ADYEN: AMS) is the financial technology platform of choice for leading companies. By providing end-to-end payments capabilities, data-driven insights, and financial products in a single global solution, Adyen helps businesses achieve their ambitions faster. With offices around the world, Adyen works with the likes of Meta, Uber, H&M, eBay, and Microsoft. The cooperation with LillyDirect as described in this merchant update underlines Adyen's continuous growth with current and new merchants over the years.
View original content to download multimedia:https://www.prnewswire.com/news-releases/adyen-to-provide-payment-technology-services-for-lillydirect-302842376.html
SOURCE Adyen
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nasdaq Entrepreneurial Center launches Northwest Arkansas program to help small businesses grow and connect students to paid internships
- AllOne Health Named to the 2026 Inc. 5000 List of America's Fastest-Growing Private Companies
- Next Crypto To Explode: AI Is Stealing Money From Bitcoin, Could AlphaPepe’s AI-Meme Setup Be the Rotation Retail Misses?
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share